Toxicology – Pyridoxine (Vitamin B6)

Core Concept

Pyridoxine (vitamin B6) is a water-soluble vitamin with an important antidotal role in poisoning that produces functional pyridoxal-5′-phosphate deficiency, particularly isoniazid (INH) toxicity.

Its major toxicologic uses are:

• Isoniazid-induced seizures or coma
• Significant Gyromitra mushroom / gyromitrin-related hydrazine toxicity
• Prevention or treatment of pyridoxine deficiency during therapeutic INH use
• Selected deficiency states caused by pyridoxine-antagonist drugs

Pyridoxine has also been proposed as an adjunct in ethylene glycol poisoning, but this is a secondary and weakly supported role compared with alcohol dehydrogenase blockade and, when indicated, hemodialysis.

Biochemical Role

Pyridoxine is converted to its active coenzyme form:

Pyridoxal-5′-phosphate (PLP)

PLP participates in numerous biochemical reactions, particularly:

• Amino-acid metabolism
• Transamination
• Decarboxylation
• Neurotransmitter synthesis
• Heme-related metabolism

Its toxicologic importance is especially related to GABA synthesis.

GABA Formation

PLP is required by glutamate decarboxylase for conversion of glutamate to GABA.

Conceptually:

Glutamate → GABA

with PLP acting as an essential cofactor.

GABA is the major inhibitory neurotransmitter in the CNS.

Loss of available PLP can therefore cause:

↓ GABA synthesis → loss of inhibitory signaling → severe seizures

Isoniazid Toxicity

Isoniazid is the classic poisoning in which pyridoxine functions as a specific antidote.

Severe acute INH poisoning classically produces:

• Refractory seizures
• Altered mental status or coma
• High-anion-gap metabolic acidosis

This triad should strongly raise suspicion for INH when the exposure history is uncertain.

How Isoniazid Causes Seizures

INH and its metabolites interfere with pyridoxine metabolism and reduce availability of active PLP.

Consequently:

INH → functional PLP depletion → ↓ glutamate decarboxylase activity → ↓ GABA → seizures

This explains why conventional anticonvulsants alone may fail.

Other Effects of Severe INH Poisoning

Patients may develop:

• Recurrent or status epilepticus
• Coma
• Severe lactic acidosis
• Hyperthermia secondary to seizures
• Rhabdomyolysis
• Hypotension
• Respiratory failure
• Secondary organ injury

The metabolic acidosis often reflects intense seizure activity and impaired cellular metabolism.

Pyridoxine as a Specific Antidote

Pyridoxine replenishes the depleted vitamin B6 pool and restores formation of PLP.

This permits GABA synthesis to recover and directly addresses an important mechanism of INH-induced seizures.

Therefore:

Pyridoxine + benzodiazepines are complementary treatments.

Seizure Management

Benzodiazepines remain important initial anticonvulsants.

However, when INH poisoning is known or strongly suspected:

Pyridoxine should be given promptly rather than repeatedly escalating conventional anticonvulsants alone.

Persistent seizures require:

• Airway management
• Oxygenation and ventilation
• Pyridoxine
• Benzodiazepines
• Correction of glucose/electrolyte abnormalities
• Management of hyperthermia and rhabdomyolysis

Additional anticonvulsant/anesthetic therapy may be required in refractory status epilepticus.

Why Benzodiazepines and Pyridoxine Work Together

Benzodiazepines enhance activity at existing GABA-A receptors.

Pyridoxine helps restore the body’s ability to produce GABA.

Thus, they attack the seizure process at complementary points.

Phenytoin Is Not the Preferred Mechanistic Therapy

INH seizures result primarily from severe disruption of inhibitory GABA physiology rather than a conventional isolated epileptic mechanism.

Therefore, phenytoin does not correct the underlying pyridoxine deficiency and should not replace:

• Pyridoxine
• Benzodiazepines
• Appropriate supportive care

Unknown-Cause Refractory Seizures

Historically, empiric pyridoxine was recommended broadly for unexplained seizures.

Modern practice is more targeted.

Pyridoxine should be strongly considered when refractory seizures occur with clues suggesting:

• INH exposure
• Tuberculosis treatment
• Intentional medication overdose
• Gyromitra mushroom exposure
• Hydrazine-related poisoning
• Compatible severe metabolic acidosis

It is not a universal antidote for every unexplained seizure.

Prophylaxis During Isoniazid Therapy

Therapeutic INH can gradually produce pyridoxine deficiency and peripheral neuropathy.

Preventive pyridoxine is particularly important in patients with increased risk, including:

• Pregnancy
• Malnutrition
• Diabetes
• HIV infection
• Chronic kidney disease
• Alcohol use disorder
• Pre-existing neuropathy

Clinical protocols determine supplementation requirements.

INH-Associated Peripheral Neuropathy

Chronic pyridoxine deficiency can produce:

• Paresthesias
• Burning discomfort
• Numbness
• Distal sensory abnormalities
• Peripheral neuropathy

This differs from the dramatic seizure syndrome of acute massive INH poisoning.

Gyromitra Mushroom Poisoning

Some Gyromitra species contain gyromitrin.

Gyromitrin is metabolized to monomethylhydrazine (MMH), a hydrazine compound capable of interfering with vitamin B6-dependent metabolism.

Clinical manifestations may include:

• Nausea
• Vomiting
• Abdominal pain
• Diarrhea
• Dizziness
• Altered mental status
• Seizures

Severe cases may also produce:

• Hepatic injury
• Hemolysis
• Metabolic disturbances
• Coma

Pyridoxine in Gyromitra Toxicity

When significant Gyromitra/MMH poisoning causes seizures or severe neurologic toxicity, pyridoxine is an important antidotal treatment.

As with INH:

Pyridoxine restores PLP-dependent inhibitory neurotransmitter synthesis.

Supportive care remains essential.

Penicillamine and Pyridoxine

Long-term penicillamine therapy can interfere with pyridoxine metabolism.

For that reason, patients receiving prolonged penicillamine treatment may require vitamin B6 supplementation.

However, the older description of pyridoxine as a standard antidote for “penicillamine poisoning” is too broad.

Its main role is prevention or correction of penicillamine-associated pyridoxine deficiency, rather than treatment of all manifestations of penicillamine toxicity.

Hydralazine

Hydralazine can interfere with pyridoxine metabolism and has been associated with peripheral neuropathy during prolonged treatment.

Pyridoxine may be used when clinically appropriate for deficiency-related neurologic effects.

Cycloserine

Cycloserine can also antagonize pyridoxine-dependent pathways.

Vitamin B6 supplementation may reduce some neurologic adverse effects during prolonged treatment.

Ethylene Glycol

Ethylene glycol is metabolized through several toxic intermediates:

Ethylene glycol → glycolaldehyde → glycolate → glyoxylate → oxalate

Major consequences include:

• High-anion-gap metabolic acidosis
• Hypocalcemia
• Calcium oxalate deposition
• Acute kidney injury
• CNS and cardiovascular toxicity

Proposed Role of Pyridoxine in Ethylene Glycol Poisoning

Pyridoxine has historically been proposed to encourage metabolism of glyoxylate toward less harmful products rather than oxalate.

Thiamine has a similar theoretical adjunctive role through another pathway.

However:

Clinical evidence that pyridoxine meaningfully improves outcomes is limited.

It should be regarded as a secondary adjunct rather than a central antidote.

Primary Treatment of Ethylene Glycol Poisoning

Modern management emphasizes:

• Fomepizole to inhibit alcohol dehydrogenase
• Supportive management
• Correction of severe metabolic abnormalities
• Calcium management when clinically indicated
• Hemodialysis for selected severe poisoning

Pyridoxine and thiamine should never delay these definitive interventions.

Levodopa Interaction

Pyridoxine increases peripheral conversion of levodopa to dopamine by supporting aromatic L-amino-acid decarboxylase.

This can reduce the amount of levodopa reaching the brain when levodopa is given without a peripheral decarboxylase inhibitor.

However, modern Parkinson therapy usually combines levodopa with carbidopa.

Carbidopa blocks peripheral decarboxylation, making the classic pyridoxine–levodopa interaction far less clinically important.

Adverse Effects

Pyridoxine is generally well tolerated when appropriately used.

The major toxicity of excessive exposure is sensory neuropathy, particularly with prolonged high intake.

Pyridoxine-Induced Neuropathy

Excess vitamin B6 can damage sensory neurons.

Possible manifestations include:

• Numbness
• Paresthesias
• Burning sensations
• Impaired vibration/proprioception
• Sensory ataxia
• Gait disturbance

Severe toxicity can produce substantial functional impairment.

Acute vs Chronic Toxicity

The older source emphasizes very large single exposures.

Modern concern is more commonly focused on repeated excessive supplementation, because neuropathy has been reported with chronic intake well below historical massive-dose descriptions.

Therefore:

“Water-soluble vitamin” does not mean unlimited intake is harmless.

Recovery From Pyridoxine Neuropathy

Symptoms may improve after excessive supplementation is stopped, but recovery can be:

• Slow
• Incomplete in severe cases

A careful supplement history is important in otherwise unexplained sensory neuropathy.

Hypersensitivity

True hypersensitivity to pyridoxine is uncommon but remains a reason to avoid re-exposure when clearly documented.

Pregnancy

The historical FDA pregnancy letter categories are obsolete.

Vitamin B6 is a normal nutritional requirement during pregnancy.

Pyridoxine supplementation is commonly used in appropriate nutritional and therapeutic contexts.

When severe INH poisoning occurs during pregnancy, potentially life-saving antidotal pyridoxine should not be withheld because of pregnancy.

If IV Pyridoxine Is Not Immediately Available

Severe INH poisoning is an emergency in which adequate parenteral antidote availability can become a practical problem.

Management should involve:

• Immediate airway and seizure care
• Pharmacy involvement
• Poison-center/medical-toxicology consultation
• Rapid acquisition of an appropriate pyridoxine formulation

Historical improvised enteral replacement strategies should not delay definitive emergency treatment or airway management.

Monitoring in Severe INH Poisoning

Important monitoring includes:

• Airway and ventilation
• Continuous ECG
• Neurologic status
• Seizure activity
• Blood glucose
• Electrolytes
• Blood gas
• Bicarbonate
• Anion gap
• Lactate
• Temperature
• Creatine kinase
• Renal function

Persistent coma after visible convulsions stop may warrant consideration of ongoing nonconvulsive seizure activity and EEG monitoring.

Rhabdomyolysis

Prolonged seizures can cause:

• Marked CK elevation
• Hyperkalemia
• Myoglobinuria
• Acute kidney injury

Management includes seizure termination and appropriate fluid/electrolyte/renal monitoring.

Metabolic Acidosis

Severe acidosis in INH poisoning commonly reflects prolonged seizure activity and lactate accumulation.

The fundamental treatment is:

Stop the seizures and correct the underlying toxic mechanism.

Acid-base abnormalities should be followed serially during resuscitation.

Important Modernization of the Older Source

• Pyridoxine is converted to pyridoxal-5′-phosphate (PLP), an essential cofactor for GABA synthesis.
• INH produces functional vitamin B6 deficiency, reducing GABA and causing potentially refractory seizures.
• Pyridoxine is the specific antidote for severe INH neurotoxicity.
• Benzodiazepines and pyridoxine have complementary actions and are commonly used together.
• Pyridoxine should be considered early when refractory seizures occur in a setting suggestive of INH or hydrazine exposure.
• It is not necessary to administer pyridoxine empirically for every unexplained seizure.
• Gyromitra/gyromitrin toxicity can generate MMH and cause a similar functional pyridoxine deficiency.
• Pyridoxine is useful for significant Gyromitra-associated seizures.
• Penicillamine, hydralazine, and cycloserine can contribute to pyridoxine deficiency, particularly during prolonged therapy.
• Pyridoxine’s role in ethylene glycol poisoning is adjunctive and supported mainly by biochemical rationale, not strong clinical outcome evidence.
• Fomepizole and, when indicated, hemodialysis are far more important in serious ethylene glycol poisoning.
• The classic levodopa interaction is largely prevented when levodopa is combined with carbidopa.
• Chronic excessive vitamin B6 supplementation can itself cause significant sensory neuropathy.
• Historical FDA pregnancy categories are obsolete.
• Exact emergency antidotal dosing should follow current poison-center or medical-toxicology protocols.

Key Points

• INH → functional PLP depletion → ↓ GABA → refractory seizures.
• Pyridoxine restores PLP-dependent GABA synthesis.
• Severe INH poisoning classically produces seizures + coma/altered consciousness + high-anion-gap metabolic acidosis.
• Pyridoxine and benzodiazepines are complementary treatments for INH-induced seizures.
• Gyromitra mushroom toxicity can cause a similar hydrazine-mediated seizure syndrome and may respond to pyridoxine.
• Pyridoxine is only a secondary adjunct in ethylene glycol poisoning and must not delay fomepizole or dialysis when indicated.
• Long-term penicillamine, hydralazine, or cycloserine can increase the risk of vitamin B6 deficiency.
• Excessive chronic pyridoxine can paradoxically cause sensory neuropathy.
• In suspected INH toxicity, correcting the underlying pyridoxine-dependent metabolic defect is essential rather than relying on conventional anticonvulsants alone.